A human electrophysiological signature of Fragile X pathophysiology is shared in V1 of Fmr1-/y mice
Open Access
- 9 February 2026
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Abstract
Predicting clinical therapeutic outcomes from animal studies using conserved electrophysiological phenotypes could facilitate developing treatments for neuropsychiatric disorders. Alpha oscillations in human resting-state electroencephalogram recordings are altered in many disorders, but whether these disruptions exist in mouse models is unknown. Here, we employed a uniform analytical method to show in males with fragile X syndrome (FXS) that alpha oscillations in humans and alpha-like oscillations in the visual cortex of Fmr1 -/y mice are slowed, with a stronger phenotype in adults than juveniles and a juvenile-specific power phenotype in both species. We find that alpha-like oscillations are disrupted by deletion of Fmr1 in cortical excitatory neurons and glia, reflect differential activity of two classes of GABAergic interneurons, and are more sensitive to activation of GABA B receptors by Arbaclofen in wild-type than Fmr1 -/y mice. Our framework reveals evolutionary conservation of alpha oscillation disruptions, enables a deeper understanding of FXS pathophysiology, and narrows the gap between treatment promise and practice.Keywords
Funding Information
- U.S. Department of Health & Human Services | National Institutes of Health (1K23DC017983-01A1)
- U.S. Department of Health & Human Services | National Institutes of Health (1T32MH112510)
- U.S. Department of Health & Human Services | National Institutes of Health (U54HD082008)
- U.S. Department of Health & Human Services | National Institutes of Health (U54HD104461)
- U.S. Department of Health & Human Services | National Institutes of Health (K23 HD101416)
- U.S. Department of Health & Human Services | National Institutes of Health (F31 HD113221-01A1)
- U.S. Department of Health & Human Services | National Institutes of Health (R01EY023037)
- U.S. Department of Health & Human Services | National Institutes of Health (R21NS123499)
- National Science Foundation (GRFP)
- FRAXA Research Foundation
- Autism Science Foundation
- Thrasher Research Fund
- Harvard Catalyst
- Simons Foundation (SFARI 575135)
- RCUK | Biotechnology and Biological Sciences Research Council (BB/S008276/1)
This publication has 120 references indexed in Scilit:
- Reliability of resting-state electrophysiology in fragile X syndromeBiomarkers in Neuropsychiatry, 2023
- The organization and development of cortical interneuron presynaptic circuits are area specificCell Reports, 2021
- Restoration of FMRP expression in adult V1 neurons rescues visual deficits in a mouse model of fragile X syndromeProtein & Cell, 2021
- Somatostatin Neurons Govern Theta Oscillations Induced by Salient Visual SignalsCell Reports, 2020
- Enhancing the Utility of Preclinical Research in Neuropsychiatry Drug Development2019
- Reduced frontal gamma power at 24 months is associated with better expressive language in toddlers at risk for autismAutism Research, 2019
- Abnormal maturation of the resting‐state peak alpha frequency in children with autism spectrum disorderHuman Brain Mapping, 2019
- β-Arrestin2 Couples Metabotropic Glutamate Receptor 5 to Neuronal Protein Synthesis and Is a Potential Target to Treat Fragile XCell Reports, 2017
- The mGluR Theory of Fragile X: From Mice to Men2017
- Reduced alpha and exaggerated theta power during the resting-state EEG in fragile X syndromeBiological Psychology, 2013